Recently, Australian Trefoil Health Technologies Pty Ltd successfully organized a high-level internal technical seminar, co-hosted by the company's co-founder Dr. Jianguo Yang (pioneer in selenoprotein P research and recognized as the "Father of Selenoprotein P") and Dr. Minoo Moghaddam (expert in nanomedicine and drug delivery, former Senior Principal Research Scientist at CSIRO, and co-founder of NanoMed with over 25 years of experience in nanotechnology for medical applications).
The seminar brought together core members of the Nano Tec team (nanotechnology R&D group) and the Formulation Group to engage in in-depth discussions on enhancing the bioavailability of plant flavonoid active compounds—such as curcumin, fisetin, and quercetin—and the promising prospects of nanotechnology in improving their absorption efficiency. The group also conducted strategic planning for the next phase of new product development roadmap.
Plant flavonoids like curcumin, fisetin, and quercetin are highly valued for their potent antioxidant, anti-inflammatory, anti-aging, and potential neuroprotective effects, serving as core raw materials in the company's current research focus on anti-aging and degenerative diseases. However, these natural bioactive compounds commonly face bioavailability bottlenecks, including poor water solubility, low intestinal absorption rates, and strong first-pass effects, which limit their practical efficacy in functional nutrition and health products.
During the seminar, the Nano Tec team presented several cutting-edge nano-delivery strategies, including liposomes, polymeric nanoparticles, micelles, nanocrystals. These approaches can significantly enhance the solubility, stability, targeting, and transmembrane permeability of flavonoids. Dr. Minoo Moghaddam, drawing on her extensive expertise in nano-drug delivery, highlighted the unique advantages of lipid-based nanocarriers and protein-polysaccharide composite systems in protecting active ingredients from gastrointestinal degradation, prolonging circulation time, and enabling colon-targeted release. Dr. Jianguo Yang analyzed from a molecular biology perspective how these nano-strategies can synergistically enhance selenoprotein-related pathways, amplifying the antioxidant and cellular repair potential of flavonoids.
Participants unanimously agreed that nanotechnology is not only a key pathway to overcoming bioavailability challenges but also a critical engine driving the company's transition from traditional nutritional supplements to high-tech precision health products. Consensus was reached on specific product development directions, including:
This seminar further reinforced Trefoil's core philosophy: "Technology is productivity, innovation is competitiveness." It exemplifies the company's strength in multidisciplinary cross-integration. Moving forward, we will continue to deepen the integration of nanotechnology with natural active ingredients, delivering more efficient and reliable solutions to global health challenges.
Special thanks to Dr. Yang and Dr. Moghaddam for their excellent hosting, and to all participating teams for their enthusiastic contributions!
For more details on the discussions or follow-up actions, please contact the R&D Department or Nano Tec team.
Proudly driving health innovation
